BACKGROUND AND PURPOSE: GM is typically affected in HD since the presymptomatic stage. Our aim was to investigate with MT MR imaging the microstructural changes of the residual brain subcortical and cortical GM in carriers of the HD gene and to preliminarily assess their correlation with the clinical features. MATERIALS AND METHODS: Fifteen HD gene carriers with a range of clinical severity and 15 age- and sex-matched healthy controls underwent MT MR imaging on a 1.5T scanner. The MT ratio was measured automatically in several subcortical and cortical GM regions (striatal nuclei; thalami; and the neocortex of the frontal, temporal, parietal, and occipital lobes) by using FLS tools. RESULTS: The MT ratio was significantly (P < .05 with Bonferroni correction for multiple comparison) decreased in all subcortical structures except the putamen and decreased diffusely in the cerebral cortex of HD carriers compared with controls. Close correlation was observed between the subcortical and cortical regional MT ratios and several clinical variables, including disease duration, motor disability, and scores in timed neuropsychological tests. CONCLUSIONS: MT imaging demonstrates degeneration of the subcortical and cortical GM in HD carriers and might serve, along with volumetric assessment, as a surrogate marker in future clinical trials of HD.
BACKGROUND AND PURPOSE:GM is typically affected in HD since the presymptomatic stage. Our aim was to investigate with MT MR imaging the microstructural changes of the residual brain subcortical and cortical GM in carriers of the HD gene and to preliminarily assess their correlation with the clinical features. MATERIALS AND METHODS: Fifteen HD gene carriers with a range of clinical severity and 15 age- and sex-matched healthy controls underwent MT MR imaging on a 1.5T scanner. The MT ratio was measured automatically in several subcortical and cortical GM regions (striatal nuclei; thalami; and the neocortex of the frontal, temporal, parietal, and occipital lobes) by using FLS tools. RESULTS: The MT ratio was significantly (P < .05 with Bonferroni correction for multiple comparison) decreased in all subcortical structures except the putamen and decreased diffusely in the cerebral cortex of HD carriers compared with controls. Close correlation was observed between the subcortical and cortical regional MT ratios and several clinical variables, including disease duration, motor disability, and scores in timed neuropsychological tests. CONCLUSIONS: MT imaging demonstrates degeneration of the subcortical and cortical GM in HD carriers and might serve, along with volumetric assessment, as a surrogate marker in future clinical trials of HD.
Authors: D C Rubinsztein; J Leggo; R Coles; E Almqvist; V Biancalana; J J Cassiman; K Chotai; M Connarty; D Crauford; A Curtis; D Curtis; M J Davidson; A M Differ; C Dode; A Dodge; M Frontali; N G Ranen; O C Stine; M Sherr; M H Abbott; M L Franz; C A Graham; P S Harper; J C Hedreen; M R Hayden Journal: Am J Hum Genet Date: 1996-07 Impact factor: 11.025
Authors: Robert Jech; Jirí Klempír; Josef Vymazal; Jana Zidovská; Olga Klempírová; Evzen Růzicka; Jan Roth Journal: Mov Disord Date: 2007-09-15 Impact factor: 10.338
Authors: M Muglia; O Leone; G Annesi; A L Gabriele; E Imbrogno; C Grandinetti; F L Conforti; F Naso; C Brancati Journal: Clin Chem Date: 1996-10 Impact factor: 8.327
Authors: Mario Mascalchi; Francesco Lolli; Riccardo Della Nave; Carlo Tessa; Raffaele Petralli; Cinzia Gavazzi; Letterio S Politi; Marco Macucci; Massimo Filippi; Silvia Piacentini Journal: Radiology Date: 2004-06-23 Impact factor: 11.105
Authors: Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos Journal: J Neurol Date: 2009-10-13 Impact factor: 4.849
Authors: M Cosottini; I Pesaresi; S Piazza; S Diciotti; G Belmonte; M Battaglini; A Ginestroni; G Siciliano; N De Stefano; M Mascalchi Journal: AJNR Am J Neuroradiol Date: 2011-03-24 Impact factor: 3.825
Authors: S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos Journal: AJNR Am J Neuroradiol Date: 2012-01-12 Impact factor: 3.825
Authors: Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi Journal: Nat Rev Neurol Date: 2014-03-11 Impact factor: 42.937
Authors: S J A van den Bogaard; E M Dumas; E P Hart; J Milles; R Reilmann; J C Stout; D Craufurd; C R Gibbard; S J Tabrizi; M A van Buchem; J van der Grond; R A C Roos Journal: AJNR Am J Neuroradiol Date: 2012-08-23 Impact factor: 3.825
Authors: Nicola De Stefano; Maria Laura Stromillo; Francesca Rossi; Marco Battaglini; Antonio Giorgio; Emilio Portaccio; Bahia Hakiki; Gianmichele Malentacchi; Claudio Gasperini; Mario Santangelo; Maria Letizia Bartolozzi; Maria Pia Sormani; Antonio Federico; Maria Pia Amato Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240
Authors: Andreia V Faria; J Tilak Ratnanather; Daniel J Tward; David Soobin Lee; Frieda van den Noort; Dan Wu; Timothy Brown; Hans Johnson; Jane S Paulsen; Christopher A Ross; Laurent Younes; Michael I Miller Journal: Neuroimage Clin Date: 2016-02-26 Impact factor: 4.881